Also reported were the results of a study evaluating outcomes of persons at high risk for lung cancer who were referred for and underwent LDCT lung cancer screening at a comprehensive cancer center.

Of the 485 participants who underwent lung cancer screening over a 3-month period, LDCT findings were categorized as negative, probably benign, and requiring additional testing in 74%, 5%, and 8%, respectively. Of the 39 patients included in the latter category, stage I/II, stage III, and stage IV lung cancer were diagnosed in 6, 1, and 1 participant(s), respectively.

“Lung cancer screening with [LDCT] detects lung cancer in earlier stages and reduces mortality,” Dr Howard emphasized in her closing remarks.